A side-by-side comparison of Harvest Healthcare Leaders Income ETF (HHL) and First Trust Nasdaq Pharmaceuticals ETF (FTXH) to help Canadian investors make an informed decision.
1-Year Performance
Normalised to 100 at the start — shows relative return over the trailing 12 months.
Head-to-Head Comparison
| Metric | HHL | FTXH |
|---|---|---|
| YTD Return | -0.39% | +23.13%✓ |
| 1-Day Change | +0.79% | +1.22%✓ |
| 1-Week Change | +0.39% | +1.33%✓ |
| 1-Month Change | +4.48%✓ | +5.55% |
| Current Price | $7.69 | $43.77 |
| AUM | $1.96B✓ | $1.15B |
| MER (Expense Ratio) | — | 0.57% |
| Dividend Yield | 9.59%✓ | 0.71% |
| Distribution Frequency | — | NA |
| Inception Date | 2014-12-18 | 2016-09-20 |
| Holdings Count | 10 | 50 |
| MorningStar Rating | — | — |
| Category | Healthcare Equity | Healthcare Equity |
| Beta | 0.97 | 0.43 |
| 52-Week High | $7.70 | $44.19 |
| 52-Week Low | $6.35 | $29.60 |
| 50-Day MA | $7.43 | $41.60 |
| 200-Day MA | $7.27 | $37.09 |
✓ marks the better value for return/yield/AUM metrics. Lower ✓ for MER.
Annualised Returns
| Period | HHL | FTXH |
|---|---|---|
| YTD | -0.39% | +23.13%✓ |
| 1 Year | +12.02% | +46.14%✓ |
| 3 Year | +11.38% | +24.37%✓ |
| 5 Year | +7.35% | +13.05%✓ |
| 10 Year | +8.93% | +10.16%✓ |
| 1Y Volatility | 12.56% | 13.63% |
| Sharpe Ratio (3Y) | 0.37 | 0.96 |
Past performance is not a guarantee of future results.
Top 10 Holdings
| 1 | A | Agilent Technologies Inc | 6.38% |
| 2 | TMO | Thermo Fisher Scientific Inc | 5.92% |
| 3 | ISRG | Intuitive Surgical Inc | 5.86% |
| 4 | DHR | Danaher Corporation | 5.74% |
| 5 | AMGN | Amgen Inc | 5.65% |
| 6 | VRTX | Vertex Pharmaceuticals Inc | 5.67% |
| 7 | REGN | Regeneron Pharmaceuticals Inc | 5.41% |
| 8 | MRK | Merck & Company Inc | 5.19% |
| 9 | JNJ | Johnson & Johnson | 4.95% |
| 10 | ABBV | AbbVie Inc | 4.91% |
| 1 | ABBV | AbbVie Inc | 7.51% |
| 2 | LLY | Eli Lilly and Company | 7.55% |
| 3 | PFE | Pfizer Inc | 7.00% |
| 4 | JNJ | Johnson & Johnson | 7.19% |
| 5 | MRK | Merck & Company Inc | 6.52% |
| 6 | BIIB | Biogen Inc | 3.86% |
| 7 | VTRS | Viatris Inc | 3.73% |
| 8 | GILD | Gilead Sciences Inc | 3.73% |
| 9 | AMGN | Amgen Inc | 3.71% |
| 10 | UTHR | United Therapeutics Corporation | 3.70% |
Sector Weights
| Sector | HHL | FTXH |
|---|---|---|
| Basic Materials | 0.00% | 0.00% |
| Communication Services | 0.00% | 0.00% |
| Consumer Cyclicals | 0.00% | 0.00% |
| Consumer Defensive | 0.00% | 0.00% |
| Energy | 0.00% | 0.00% |
| Financial Services | 0.00% | 0.00% |
| Healthcare | 100.00% | 100.00% |
| Industrials | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% |
| Technology | 0.00% | 0.00% |
| Utilities | 0.00% | 0.00% |
About HHL
US healthcare companies combine innovation with consistent demand. We all need healthcare, especially as the developed world ages and the developing world gets richer. Healthcare companies create value from new drugs, treatments, and technologies. HHL offers steady income and growth opportunities from large-cap US healthcare leaders.
About FTXH
The fund will normally invest at least 80% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.
Which ETF is Right for You?
Both HHL and FTXH are listed on Canadian exchanges and accessible through most Canadian brokerages including Questrade, Wealthsimple Trade, TD Direct, and Interactive Brokers.
Based on the available data, HHL scores higher across our tracked metrics including YTD performance, dividend yield, and AUM — though both ETFs warrant individual research before investing.
- Consider your account type (TFSA, RRSP, non-registered) as it can affect dividend taxation.
- Compare management expense ratios (MER) directly on each provider's website.
- Look at average daily trading volume to assess liquidity.
- Review the fund's underlying index and holdings to ensure the exposure matches your goals.
This is not financial advice. Always do your own research or consult a licensed financial advisor before investing.
Frequently Asked Questions
What is the difference between HHL and FTXH?
HHL (Harvest Healthcare Leaders Income ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are both Canadian-listed ETFs. Key differences include their AUM ($1.96B vs $1.15B), dividend yield (9.59% vs 0.71%), and year-to-date performance (-0.39% vs +23.13%).
Is HHL better than FTXH?
There is no single "better" ETF — it depends on your investment goals. If you prioritise dividends, compare both yields and choose based on your income needs. Always review the fund's prospectus and consider your tax situation.
Can I buy HHL and FTXH on Wealthsimple?
Most Canadian-listed ETFs are available on Wealthsimple Trade commission-free. Both HHL and FTXH should be accessible. Check Wealthsimple's supported tickers list to confirm availability.
7 stocks to buy and hold forever
Complement your ETF portfolio with these proven long-term individual stocks.
Get the FREE Report